Novel BET protein proteolysis-Targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

D. T. Saenz, W. Fiskus, Y. Qian, T. Manshouri, K. Rajapakshe, K. Raina, K. G. Coleman, A. P. Crew, A. Shen, C. P. Mill, B. Sun, P. Qiu, T. M. Kadia, N. Pemmaraju, C. Dinardo, M. S. Kim, A. J. Nowak, C. Coarfa, C. M. Crews, S. VerstovsekK. N. Bhalla

Research output: Contribution to journal › Article › peer-review

148 Scopus citations

Fingerprint

Dive into the research topics of 'Novel BET protein proteolysis-Targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells'. Together they form a unique fingerprint.

Medicine & Life Sciences